Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03478514
Title Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
St. Joseph Mercy Hospital Cancer Care Center Ypsilanti Michigan 48197 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Medical University of South Carolina - Hollings Cancer Center Charleston South Carolina 29425 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field